OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Neha Vapiwala: A Conversation With Mark Cuban on the Future of Healthcare

Targeted Therapy Resistance in NSCLC: Critical Next Steps

The Dangers We Fear and the Everyday Risks We Learn to Ignore

Aleksandra Filipovic: Opening the Oncology Couch to the Global Cancer Community

An Evening for Cure: Fundraising Gala to Support New Comprehensive Cancer Center in Ghana

Oncology News, Insights, Stories by OncoDaily

President of Botswana Duma Boko
OncoDaily Magazine

The Hidden Gem in the Land of Gems: A Harvard-trained human rights lawyer is opening Botswana's doors to the biomedical industry — and the world should be paying attention.

Erica Schwartz Confirmed as New CDC Director
Career Updates

Erica Schwartz Confirmed as New CDC Director

Tribute to Jorge Messi and His Support for Childhood Cancer - Guillermo Chantada
Blog Posts

Tribute to Jorge Messi and His Support for Childhood Cancer - Guillermo Chantada

Stephen Modise: Reliable Healthcare for Every Motswana Is Within Reach

1000 Voices for Cancer Equity National Listening Campaign

Monica Bertagnolli: Why We All Need to Care About What Happens to Dr. Tony Fauci

Gevorg Tamamyan: Registration Open for OncoDaily and PICI's IMMUNÕ 2026 Virtual Congress

7th Emirates Oncology Society Annual Conference 2026 Set to Bring Together Oncology Experts in Dubai

CReDO: Where Oncology Research Ideas Become Research Protocols

PRODIGE-24/CCTG PA6: Tumor Genomics and Adjuvant Chemotherapy in Resected Pancreatic Cancer

Voices
Paolo Tarantino

Paolo Tarantino: Grateful for the Warm Welcome and Meaningful Connections

Ajai Chari: Honoring Rachna Shroff by Contributing to a Young Investigator Award

Jose Martin-Moreno: Grateful to See Our Work Echoed in OncoDaily Medical Journal

Wei Zhang: Congratulations to Seha Ay Who Just Successfully Completed His Last Step of Becoming Doctor

Ronald Chen: Gilda's Club KC Providing Services to Cancer Survivors and Their Families for Free

Mel Mann: We’ve Come a Long Way Since the Old Exclusion Policies, but the Work is Still Unfinished

Norbert Kraut: Exceptional Panel on 'Case Studies in Drug Discovery and Development' at AACR D3

FDA Approvals
FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

The AACR Annual Meeting 2027

American Association for Cancer Research (AACR)

02 Apr
AACR Annual Meeting

The 3rd Edition of the International Cancer and Immuno-Oncology Conference - CIOC 2027

Magnus Group LLC

15 Mar
CIOC 2027

ACCC Oncology Reimbursement Meeting - Providence

Association of Cancer Care Centers (ACCC)

10 Nov
ACCC Oncology

The ACCC Oncology Reimbursement Meeting – Reno

Association of Cancer Care Centers (ACCC)

04 Nov
ACCC Oncology

The Fundraising Gala: An Evening for Cure - OOTII CCCoE

Otumfuo Osei Tutu II Comprehensive Cancer Center of Excellence (OOTII CCCoE)

04 Sep
OOTII CCCoE

Immune-oncology
Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Can Diet and the Gut Microbiome Improve Immunotherapy Response?

Tumor Mutational Burden Predicts Response to Neoadjuvant Immunotherapy

CRISPR in Cancer Immunotherapy and Precision Oncology

Predicting Immunotherapy Response Beyond PD-L1 and Tumor Mutational Burden

Perioperative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Gastrointestinal-Oncology
PRODIGE-24/CCTG PA6

PRODIGE-24/CCTG PA6: Tumor Genomics and Adjuvant Chemotherapy in Resected Pancreatic Cancer

EvIDHence Study: Real-World Outcomes in IDH1-Mutant and Wild-Type Cholangiocarcinoma Before mIDH1 Inhibitors

FDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer

ctDNA in Gastrointestinal Cancers: What the Evidence Shows

DESTINY-PanTumor02: T-DXd in HER2-Expressing Biliary Tract or Pancreatic Cancers

10 Must-Read Posts In GI Oncology This Week

Claudin 18.2 and FGFR2b: New Biomarkers in Gastric and Esophageal Cancer

Breast-Oncology
T-DXd

After T-DXd: Why Switching ADC Targets May Not Be Enough

HERTHENA-Breast02 Trial: Innovative Dual-ADC Strategy in HR+/HER2-Low Breast Cancer

Patient-Reported GI Toxicity Reveals Hidden Burden With Neratinib Plus T-DM1

Tumor-Derived Extracellular Vesicles Reveal Hidden MBC Risk

HORIZON-Breast01: Trastuzumab Rezetecan Delivers 30.6-Month PFS

SUPREMO: Chest Wall Radiotherapy Has Limited 5-Year QOL Impact

FeDeriCa: 4-Year Outcomes Support Subcutaneous HER2 Therapy

Lung-Oncology
Targeted Therapy

Targeted Therapy Resistance in NSCLC: Critical Next Steps

SKYSCRAPER-03 Trial: Critical Setback for TIGIT Consolidation in Stage III NSCLC

HER2 Mutations in NSCLC: Critical Risks of Outdated Terms

EGFR Amplification in EGFR-Mutated NSCLC: Critical Risk Marker

Lung Cancer in Nonsmoking Individuals: A Distinct Clinical Profile

TREASURE Trial Raises Safety Concerns for Thoracic Radiotherapy With Atezolizumab in ES-SCLC

Phase 2 Study Evaluates BIO 300 With SBRT in Early-Stage NSCLC and ILD

Oncology Tech
Replimune Tudriqev

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

Hematology
Hairy Cell Leukemia (HCL)

Hairy Cell Leukemia (HCL): A Rare Leukemia Treated Well, but Rarely Eradicated

Extramedullary Disease in Multiple Myeloma (EMD): Progress in the Immunotherapy Era

Access to TCRTs in Multiple Myeloma: Patient, Caregiver, and Physician Perspectives

Autologous Stem Cell Transplantation (ASCT) for HIV-Associated Lymphoma: Latest Evidence

BTK Inhibitors in Chronic Lymphocytic Leukemia: Current Practice and Future Perspectives

Systemic Mastocytosis: A Hematologic Neoplasm Often Mistaken for Allergy and Other Conditions

Leukemia Diagnosis: Every Step From First Symptoms to Treatment and Beyond

Radiotherapy
DBCG Skagen Trial 1

DBCG Skagen Trial 1 Validates ESTRO Target Volume Guidelines in Early Breast Cancer

One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer

10 Must-Read Posts In Radiotherapy This Week: July 27- August 2

E2-RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research

IMPulse Trial Tests FLASH Radiotherapy for Melanoma Skin Metastases

Shorter Locoregional Radiotherapy Matches Standard Treatment in High-Risk Breast Cancer

Adaptive MR-Guided SBRT Shows Low Toxicity in Prostate Cancer

OncoDaily TV
Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Not To Miss
ESO- OncoDaily

ESO College Council Elections Announced for 2027–2028

An Evening for Cure: Fundraising Gala to Support New Comprehensive Cancer Center in Ghana

Hunter Biden Opens Up About Joe Biden’s Stage 4 Prostate Cancer: “It’s Really Sad to Watch”

CReDO: Where Oncology Research Ideas Become Research Protocols

World Cancer Support Month: Support Beyond Cancer Treatment 2026

FDA Grants Accelerated Approval to Tudriqev Plus Nivolumab for Advanced Melanoma

ORR vs OS: The Debate Continues on X

OncoGrants
Inova

Inova Hematology and Oncology Fellowship 2027

ONS Congress Scholarship

ONS Congress Scholarship 2027

MRF Breakthrough

MRF Breakthrough Consortium Pilot Translational Award 2026

Clinical Innovator Grant

CRI Clinical Innovator Grant 2026–2027

CRI

CRI Clinic and Laboratory Integration Program Grant 2026

CRI IGNITE Award

CRI IGNITE Award 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Dragana Stanić Tišma

Dragana Stanić Tišma

Oncologists Location Belgrade, Serbia
Sandra D'Angelo

Sandra D'Angelo

Oncologists Location New York, USA
Myriam Chalabi

Myriam Chalabi

Oncologists Location Amsterdam, Netherlands
Jean-Yves Blay

Jean-Yves Blay

Oncologists Location Lyon, France
Joshua Brody

Joshua Brody

Oncologists Location New York, USA
Shebli Atrash

Shebli Atrash

Oncologists Location Charlotte, USA
Luiz H. de Lima Araujo

Luiz H. de Lima Araujo

Oncologists Location Rio de Janeiro, Brazil
Saima Alvi

Saima Alvi

Oncologists Location

Oncology Drugs
KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

NVL-655: Mechanism, Dose, Administration, And Clinical Trials

Fianlimab: Mechanism, Dose, Administration, And Clinical Trials

DKN-01: Promising DKK1-Targeted Therapy, Dose, Administration, and Clinical Trials

Ponsegromab: Mechanism, Clinical Trials, Presented Data, and Future Role in Cancer Cachexia

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries